19. INVESTMENT IN ASSOCIATES Group 2024 RM’000 2023 RM’000 Unquoted shares, at cost In Malaysia 4,400 5,730 4,400 5,730 Share of post-acquisition reserves 73,272 75,182 Less: Dividend received (5,554) (9,080) 72,118 71,832 On 30 October 2024, Opus International (M) Berhad (“OIM”) entered into a Share Sale Agreement to acquire the remaining 70% ownership in Opus Consultants (M) Sdn. Bhd. (“OCM”). The transaction was completed on 12 December 2024, upon which OCM transitioned from being an associate to becoming a wholly-owned subsidiary of the Group on the same date. The effect of deemed disposal is as follows: RM’000 Fair value of existing 30% equity stake in OCM (Note 44(c)) 4,159 Less: Net carrying amount of OCM upon disposal (4,158) Deemed disposal of OCM 1 Please refer to Note 44(c) for further details on the deemed disposal of the associate. Further details of the associates are disclosed in Note 45. Summarised financial information of Biomedix Solutions Sdn. Bhd. (“Biomedix”), One Medicare Sdn. Bhd. (“One Medicare”) and Sedafiat Sdn. Bhd. (“Sedafiat”), that are material associates of the Group are set out below. The summarised financial information represents the amounts in the MFRS financial statements of the associates and not the Group’s share of those amounts. (i) Summarised statements of financial position Biomedix One Medicare Sedafiat 2024 RM’000 2023 RM’000 2024 RM’000 2023 RM’000 2024 RM’000 2023 RM’000 Non-current assets 896 1,058 6,894 7,516 18,335 18,619 Current assets 80,207 76,780 113,167 135,743 119,510 112,174 Total assets 81,103 77,838 120,061 143,259 137,845 130,793 Non-current liabilities 838 4,586 990 2,984 879 3,778 Current liabilities 4,161 6,364 82,022 105,164 69,795 59,502 Total liabilities 4,999 10,950 83,012 108,148 70,674 63,280 Net assets 76,104 66,888 37,049 35,111 67,171 67,513 Notes to the Financial Statements For the year ended 31 December 2024 UEM EDGENTA BERHAD 328 Integrated Annual Report 2024
RkJQdWJsaXNoZXIy NDgzMzc=